Enrichment of superoxide dismutase 2 in glioblastoma confers to acquisition of temozolomide resistance that is associated with tumor-initiating cell subsets.
Chien CH, Chuang JY, Yang ST, Yang WB, Chen PY, Hsu TI, Huang CY, Lo WL, Yang KY, Liu MS, Chu JM, Chung PH, Liu JJ, Chou SW, Chen SH, Chang KY.
Chien CH, et al. Among authors: yang st, yang ky, yang wb.
J Biomed Sci. 2019 Oct 19;26(1):77. doi: 10.1186/s12929-019-0565-2.
J Biomed Sci. 2019.
PMID: 31629402
Free PMC article.